Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
3.05
Dollar change
+0.02
Percentage change
0.66
%
Index- P/E- EPS (ttm)-0.93 Insider Own45.75% Shs Outstand35.52M Perf Week-0.65%
Market Cap109.80M Forward P/E- EPS next Y- Insider Trans-2.48% Shs Float19.53M Perf Month2.01%
Income-33.22M PEG- EPS next Q- Inst Own51.92% Short Float / Ratio1.48% / 2.12 Perf Quarter10.51%
Sales0.00M P/S- EPS this Y- Inst Trans-3.91% Short Interest0.29M Perf Half Y36.77%
Book/sh3.47 P/B0.88 EPS next Y- ROA-22.70% Target Price2.00 Perf Year111.81%
Cash/sh3.59 P/C0.85 EPS next 5Y42.90% ROE-23.80% 52W Range1.13 - 3.10 Perf YTD84.85%
Dividend- P/FCF- EPS past 5Y- ROI-26.57% 52W High-1.61% Beta0.05
Dividend %- Quick Ratio21.89 Sales past 5Y-33.33% Gross Margin- 52W Low169.91% ATR0.05
Employees46 Current Ratio21.89 Sales Q/Q- Oper. Margin0.00% RSI (14)55.48 Volatility1.19% 1.69%
OptionableNo Debt/Eq0.00 EPS Q/Q68.65% Profit Margin- Rel Volume0.23 Prev Close3.03
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume135.73K Price3.05
Recom5.00 SMA200.63% SMA502.14% SMA20025.64% Volume31,464 Change0.66%
Date Action Analyst Rating Change Price Target Change
Feb-07-22Initiated Northland Capital Outperform $16
Jul-13-21Initiated Wedbush Outperform $40
Jul-13-21Initiated Morgan Stanley Overweight $33
Jul-13-21Initiated JP Morgan Overweight $30
Jul-13-21Initiated BofA Securities Buy $23
Oct-12-23 07:30AM
Jul-05-23 06:46AM
Jun-30-23 04:39PM
08:00AM
Jun-03-23 09:00AM
04:01PM Loading…
May-10-23 04:01PM
Apr-20-23 06:30AM
Mar-23-23 04:01PM
Feb-06-23 08:15AM
Jan-19-23 04:30PM
Nov-07-22 04:01PM
Oct-22-22 08:34AM
Oct-12-22 08:00AM
Aug-31-22 07:30AM
Aug-24-22 06:13AM
10:55AM Loading…
Aug-11-22 10:55AM
Aug-08-22 04:01PM
Aug-01-22 08:00AM
Jun-05-22 08:30AM
May-31-22 08:00AM
May-15-22 08:12AM
May-05-22 04:30PM
May-04-22 08:00AM
May-03-22 09:00AM
Apr-25-22 09:00AM
Apr-18-22 07:30AM
Mar-17-22 06:49AM
Mar-16-22 04:01PM
Mar-09-22 05:06PM
Feb-24-22 04:30PM
11:51AM Loading…
Feb-10-22 11:51AM
Feb-08-22 07:30AM
Feb-07-22 07:30AM
Jan-12-22 07:30AM
Jan-03-22 07:30AM
Dec-16-21 07:30AM
Nov-12-21 07:30AM
Nov-01-21 07:30AM
Sep-20-21 07:30AM
Sep-18-21 09:01AM
Sep-14-21 07:00AM
Sep-01-21 07:30AM
Aug-09-21 04:05PM
Aug-02-21 07:30AM
Jun-22-21 05:00PM
Jun-17-21 07:15PM
Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RENSCHLER MARKUS MDPresident and CEONov 20Option Exercise1.5384,637129,3661,073,373Nov 22 01:48 PM
Gaiero David GChief Financial OfficerNov 20Option Exercise1.6873,940124,43388,040Nov 22 01:47 PM
Novo Holdings A/S10% OwnerJul 20Sale2.75100,000275,1403,522,136Jul 20 08:01 PM
Novo Holdings A/S10% OwnerJul 19Sale2.761,9005,2473,622,136Jul 20 08:01 PM
Novo Holdings A/S10% OwnerJul 18Sale2.766,50017,9233,624,036Jul 18 08:27 PM
Novo Holdings A/S10% OwnerJul 17Sale2.7521,10058,0003,630,536Jul 18 08:27 PM
Novo Holdings A/S10% OwnerJul 14Sale2.7411,00030,1023,651,636Jul 18 08:27 PM
Novo Holdings A/S10% OwnerJun 30Sale2.63200,937529,2883,662,636Jul 03 06:29 PM
Novo Holdings A/S10% OwnerJun 27Sale1.7731,97856,6873,863,573Jun 28 09:35 PM
Novo Holdings A/S10% OwnerJun 26Sale1.798,43715,1063,895,551Jun 28 09:35 PM
Novo Holdings A/S10% OwnerJun 23Sale1.883,4236,4473,903,988Jun 23 07:17 PM
Novo Holdings A/S10% OwnerJun 22Sale1.945,0419,7833,907,411Jun 23 07:17 PM
Novo Holdings A/S10% OwnerJun 21Sale1.994,8349,6413,912,452Jun 23 07:17 PM
Novo Holdings A/S10% OwnerJun 20Sale2.117441,5733,917,286Jun 20 05:53 PM
Novo Holdings A/S10% OwnerJun 16Sale2.035,98312,1423,918,030Jun 20 05:53 PM
Novo Holdings A/S10% OwnerJun 15Sale2.0310,00220,3043,924,013Jun 20 05:53 PM
Novo Holdings A/S10% OwnerJun 14Sale2.112,8726,0503,934,015Jun 14 08:18 PM
Novo Holdings A/S10% OwnerJun 13Sale2.102,6265,5153,936,887Jun 14 08:18 PM
Novo Holdings A/S10% OwnerJun 12Sale2.069001,8583,939,513Jun 14 08:18 PM
RENSCHLER MARKUS MDPresident and CEODec 21Option Exercise1.07136,782146,060978,736Dec 23 04:47 PM
Zakrzewski Joseph SDirectorDec 07Buy1.3021,20227,563154,618Dec 08 05:09 PM